miR-186 regulates glycolysis through Glut1 during the formation of cancer-associated fibroblasts

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 10, 2014, Pages 4245-4250

  Sun, Pan ^a   Hu, Jun Wei ^b   Xiong, Wu Jun ^b   Mi, Jun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer associated fibroblast; CDK2; Glut1; miR 186

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; MESSENGER RNA; MICRORNA; MIRN186 MICRORNA, HUMAN; SLC2A1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

BIOSYNTHESIS; CELL CYCLE CHECKPOINT; CELL LINE; CELL PROLIFERATION; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; GLYCOLYSIS; HEK293 CELL LINE; HUMAN; METABOLISM; RNA INTERFERENCE; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CELL CYCLE CHECKPOINTS; CELL LINE; CELL PROLIFERATION; DOWN-REGULATION; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLYCOLYSIS; HEK293 CELLS; HUMANS; MICRORNAS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84903549539     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.10.4245     Document Type: Article

References (34)

1. Airley RE, Mobasheri A (2007). Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy, 53, 233-56.
2. Amann T, Hellerbrand C (2009). GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets, 13, 1411-27.
3. Bagga S, Bracht J, Hunter S, et al (2005). Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell, 122, 553-63.
4. Bhowmick NA, Neilson EG, Moses HL (2004). Stromal fibroblasts in cancer initiation and progression. Nature, 432, 332-7.
5. Boire A, Covic L, Agarwal A, et al (2005). PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell, 120, 303-13.
6. Brennecke J, Stark A, Russell RB, Cohen SM (2005). Principles of microRNA-target recognition. PLoS Biol, 3, 85.
7. Cai J, Wu J, Zhang H, et al (2013). miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res, 73, 756-66.
8. Calin GA, Croce CM (2006a). MicroRNA-cancer connection: the beginning of a new tale. Cancer Res, 66, 7390-4.
9. Calin GA, Croce CM (2006b). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66.
10. Dimanche-Boitrel MT, Vakaet L Jr, Pujuguet P, et al (1994). In vivo and in vitro invasiveness of a rat colon-cancer cell line maintaining E-cadherin expression: an enhancing role of tumor-associated myofibroblasts. Int J Cancer, 56, 512-21.
11. Farh KK, Grimson A, Jan C, et al (2005). The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science, 310, 1817-21.
12. Grum-Schwensen B, Klingelhofer J, Berg CH, et al (2005). Suppression of tumor development and metastasis formation in mice lacking the S100A4 (mts1) gene. Cancer Res, 65, 3772-80.
13. Huang F, Lin C, Shi YH, Kuerban G (2013). MicroRNA-101 inhibits cell proliferation, invasion, and promotes apoptosis by regulating cyclooxygenase-2 in Hela cervical carcinoma cells. Asian Pac J Cancer Prev, 14, 5915-20.
14. Kim SY, Lee YH, Bae YS (2012). MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting alpha subunit of protein kinase CKII in human colorectal cancer cells. Biochem Biophys Res Commun, 429, 173-9.
15. Kuperwasser C, Chavarria T, Wu M, et al (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA, 101, 4966-71.
16. Lai EC (2004). Predicting and validating microRNA targets. Genome Biol, 5, 115.
17. Lewis BP, Burge CB, Bartel DP (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
18. Li H, Yin C, Zhang B, et al (2013a). PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186. Carcinogenesis, 34, 2145-55.
19. Li Q, Zhang D, Wang Y, et al (2013b). MiR-21/Smad 7 signaling determines TGF-beta1-induced CAF formation. Scientific Reports, 3, 2038.
20. Lim LP, Lau NC, Garrett-Engele P, et al (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-73.
21. Lochter A, Galosy S, Muschler J, et al (1997). Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-tomesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol, 139, 1861-72.
22. Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.
23. Mathupala SP, Ko YH, Pedersen PL (2009). Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Semin Cancer Biol, 19, 17-24.
24. Olaso E, Santisteban A, Bidaurrazaga J, et al (1997). Tumordependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology, 26, 634-42.
25. Olsen PH, Ambros V (1999). The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol, 216, 671-80.
26. Olumi AF, Grossfeld GD, Hayward SW, et al (1999). Carcinomaassociated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res, 59, 5002-11.
27. Orimo A, Gupta PB, Sgroi DC, et al (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell, 121, 335-48.
28. Sternlicht MD, Lochter A, Sympson CJ, et al (1999). The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell, 98, 137-46.
29. Stetler-Stevenson WG, Aznavoorian S, Liotta LA (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol, 9, 541-73.
30. Wan SM, Lv F, Guan T (2012). Identification of genes and microRNAs involved in ovarian carcinogenesis. Asian Pac J Cancer Prev, 13, 3997-4000.
31. Wang Y, Stricker HM, Gou D, Liu L (2007). MicroRNA: past and present. Front Biosci, 12, 2316-29.
32. Warburg O (1956). [Origin of cancer cells]. Oncologia, 9, 75-83.
33. Xie X, Lu J, Kulbokas EJ, et al (2005). Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature, 434, 338-45.
34. Yang JH, Li JH, Shao P, et al (2011). starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic acids research, 39, 202-9.